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Abstract
Sixty-five percent of Americans are over-weight. While the neuroendocrine controls of energy homeostasis are well known,
how sensory systems respond to and are impacted by obesity is scantily understood. The main accepted function of the
olfactory system is to provide an internal depiction of our external chemical environment, starting from the detection of
chemosensory cues. We hypothesized that the system additionally functions to encode internal chemistry via the detection
of chemicals that are important indicators of metabolic state. We here uncovered that the olfactory bulb (OB) subserves as
an internal sensor of metabolism via insulin-induced modulation of the potassium channel Kv1.3. Using an adult slice
preparation of the olfactory bulb, we found that evoked neural activity in Kv1.3-expressing mitral cells is enhanced following
acute insulin application. Insulin mediated changes in mitral cell excitability are predominantly due to the modulation of
Kv1.3 channels as evidenced by the lack of effect in slices from Kv1.3-null mice. Moreover, a selective Kv1.3 peptide blocker
(ShK186) inhibits more than 80% of the outward current in parallel voltage-clamp studies, whereby insulin significantly
decreases the peak current magnitude without altering the kinetics of inactivation or deactivation. Mice that were
chronically administered insulin using intranasal delivery approaches exhibited either an elevation in basal firing frequency
or fired a single cluster of action potentials. Following chronic administration of the hormone, mitral cells were inhibited by
application of acute insulin rather than excited. Mice made obese through a diet of ,32% fat exhibited prominent changes
in mitral cell action potential shape and clustering behavior, whereby the subsequent response to acute insulin stimulation
was either attenuated or completely absent. Our results implicate an inappropriate neural function of olfactory sensors
following exposure to chronic levels of the hormone insulin (diabetes) or increased body weight (obesity).
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Introduction
It has been written that the olfactory system provides ‘‘an internal
depiction of our external world’’ through the capture of odorant
molecules in the main olfactory epithelium by several large families
of G-protein coupled receptors. These receptors transduce the
chemosignals into electrical signals that travel via topographically
defined projections into the olfactory bulb [1]. We have uncovered
that the mitral cells of the olfactory bulb, the first synaptic relay from
the periphery to higher central targets such as the piriform cortex,
function as internal chemical sensors of metabolic state by
modulating a voltage-gated potassium channel predominantly
expressed in these neurons [2]. Kv1.3, a mammalian homolog of
the Shaker subfamily of potassium channels, carries a large
proportion of the outward current in the mitral cell [3] and has
multiple regulatory roles that are attributed to its structure and
position as a central scaffold upon which tyrosine kinase signaling
molecules form protein-protein interactions to modulate its function
[4–6]. Gene-targeted deletion of Kv1.3 has revealed unusual non-
conductive roles for this channel beyond those of traditional
potassium channels, which are basically dampeners of excitability
through timing of the interspike interval and shaping of the action
potential, as well as controllers of the resting membrane potential
[7]. Loss of function studies using whole-animal, targeted deletion of
the Kv1.3 gene has demonstrated that the Kv1.3-null (-/-) mice
have an enhanced olfactory ability in terms of threshold and
discrimination of molecular features, supernumerary axonal
projections to heterogeneous glomerular synaptic targets in the
olfactory bulb, and increased expression of olfactory transduction
machinery [8,9]. Seemingly unrelated to the olfactory system, the
Kv1.3-/- ‘‘Super-smeller’’ mice have metabolic alterations includ-
ing an elevated energy expenditure and locomotor activity, irregular
ingestive behaviors, resistance to diet- and genetic-induced obesity,
and increased insulin sensitivity [8,10–12]. In particular, when
challenged with a moderately high-fat diet of 32% fat for 26 weeks,
Kv1.3-/- mice fail to gain weight compared to their wild-type
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counterparts, and removal of the olfactory bulb via bilateral
olfactory bulbectomy reverses their resistance to this diet-induced
obesity (DIO) [8,13].
Given our previous biophysical characterization of the Kv1.3
channel as a substrate for insulin phosphorylation and modulation
[2], our goal was to determine the ability of the olfactory bulb to
respond to changes in insulin blood chemistry driven by the
physiological fluxes that would typically follow a meal (acute) or
during metabolic disease or obese state (chronic). Using adult
brain slices, we discovered that the duration of insulin stimulation
drives changes in mitral cell action potential firing and shape.
Mice develop a resistance to insulin modulation with the induction
of an obese, diabetic state, which has an important impact on
brain sensory function under varying states of energy utilization
[14]. Our conclusion is that odorant code information that is
inherent in spike firing frequency of mitral cells is intimately linked
with metabolic state and concomitant endocrine function.
Materials and Methods
Ethics statement
All experiments described in this report were approved by the
Florida State University Institutional Animal Care and Use
Committee (IACUC) under protocol #9912 and were conducted
Figure 1. Acute insulin stimulation of mouse olfactory bulb mitral cells causes an increase in firing frequency and inhibits spike
adaptation. (A) Laser confocal micrograph of an adult mitral cell (arrow head on soma) imaged from a YFP-thy1 mouse [19] as acquired in the mitral
cell layer (bottom inset; bright field light micrograph). G = granule cell layer, M= mitral cell layer, E = external plexiform layer. Top inset is a typical
high power view of this lamina using infrared, differential interference contrast microscopy as captured with an infrared camera. Arrow = note the
mitre shape of the neuron (hence its name) whose soma are highly concentrated in this lamina (M). (B) Line plot of the action potential spike
frequency in response to various somatic current step injections as indicated. Data represent the mean6 the standard error of the mean (s.e.m.) of 8–
10 recordings from neurons treated with control ACSF (Control) or with insulin (Insulin) for 20 minutes. * = Significantly different by paired t-test, a#
0.05. Insets (lettered arrows) are demonstrated in subsequent panels. (C, D) Representative spike trains in a mitral cell that were elicited in response to
a (C) 200 or (D) 400 pA current step of 1000 ms duration that were used to contribute to the line plot for insulin in panel A (20 minute time point;
Time 20). Time 0 represents activity prior to insulin stimulation. Activity evoked after a long duration of insulin stimulation (103 minutes; Time 103) is
also shown.
doi:10.1371/journal.pone.0024921.g001
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in accordance with the American Veterinary Medicine Association
(AVMA), the National Institutes of Health (NIH), and the UK
Home Office regulations.
Animal Care and Generation of Mutant Mouse Lines
All mice (strain C57BL6/J) were housed at the Florida State
University vivarium in accordance with institutional requirements
for animal care and were maintained on a standard 12/12 hour
light/dark cycle. Kv1.3-null (-/-) mice were generated previously
by deleting a large promoter region and the N-terminal third of
the Kv1.3 coding sequence [12]. These mice were generously
provided by Drs. Leonard Kaczmarek and Richard Flavell (Yale
University, New Haven, CT).
Diet-induced Obesity
For induction of diet-induced obesity (DIO), male mice were
placed on a moderately high-fat diet (MHF)(Research Diets
D12266B; 31.8% fat), using a matched chow diet (Purina 5001;
13.5% fat) as the control, as purchased from Research Diets (New
Brunswick, NJ) and Lab Diets (Tallahassee, FL), respectively. For
electrophysiology experiments, dams and experimental offspring
were placed on the MHF-diet at P4 so that pups would receive the
diet during postnatal development and throughout life until
sacrifice for recording. All DIO mice were weighed daily or weekly
and tail bleeds were sampled to probe for elevated blood chemistry
prior to final use.
Slice Electrophysiology
Adult mice (ages 35 to 85 days) were used for slice electrophys-
iology to facilitate insulin intranasal delivery and induction of DIO.
Mice were anesthetized by inhalation of isoflurane (Aerrane; Baxter,
Deerfield, IL), quickly decapitated, and then the olfactory bulbs
(OBs) were exposed by removing the dorsal and lateral portions of
the skull between the lambda suture and the cribriform plate. The
brain was chilled in ice-cold oxygenated (95%O2/5%CO2) sucrose-
modified artificial cerebral spinal fluid (sucrose ACSF; in mM: 83
NaCl, 26.2 NaHCO3, 1 NaH2PO4, 3.3 MgCl2, 0.5 CaCl2, 72
sucrose, 22 glucose; 315-325 mOsm, pH 7.3) for approximately 2
minutes prior to removal of the OBs for Vibratome sectioning
(Vibratome Model 1000 or Leica VT1000S, Wetzlar, Germany).
Figure 2. Insulin decreases the interspike interval (ISI) and cluster pause duration of mitral cell action potential activity. (A) (left) Line
plot of the mean ISI in response to various somatic current injections as indicated, applied for a 1000 ms duration. Same notation, sample size, and
statistical design as in Figure 1 except time point used for calculations was 15 minutes of insulin stimulation. (right) Histogram distributions of the
interspike interval (ISI) for a representative neuron prior (Control) and following insulin stimulation taken at both the 15 and 90 minute time points
(Insulin,15 min; Insulin, 90 min). Shown are three different current steps (100–300 pA). Plots were fit by Gaussian functions (solid red lines) to
determine mean ISI as reported in panel A. * = Significantly different by blocked factorial ANOVA with Student Newman Kuels (snk) followup test, a
#0.05. (B) (left) Frequency distribution plot of the pause duration between spike clusters for a neuron prior (Control, black bars) and following insulin
stimulation (Insulin, red bars) taken at the 15 minute time point. (right) The neuron was stimulated using a 10 pA perithreshold current injection of
5000 ms duration, while recording near the natural resting potential of -64 mV. A pause was defined as a lack of spike activity for greater than
100 ms, while a cluster was defined as a minimum of 3 or more action potentials, but more typically 10 to 30.
doi:10.1371/journal.pone.0024921.g002
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Coronal sections were made at a thickness of 275 mM and then
allowed to recover in an interface chamber for 30 minutes at 33uC
containing the oxygenated sucrose ACSF. Following incubation,
sections were switched into oxygenated standard ACSF (in mM:
119 NaCl, 26.2 NaHCO3, 2.5 KCl, 1 NaH2PO4, 1.3 MgCl2, 2.5
CaCl2, 22 glucose; 305-310 mOsm, pH 7.3) and held at room
temperature (rt) until use. OB slices were recorded in a continuously
perfused (Ismatec; 2 ml/min), submerged-slice recording chamber
(RC-26, Warner Instruments, Hamden, CT) using standard ACSF
plus either synaptic blockers (5 mM NBQX and 25 mM APV;
Ascent Scientific, Princeton, NJ) or various channel blockers (10 nM
TTX, 50 pM ShK-186; Sigma Chemical or Bachem, Inc.) as
deemed experimentally necessary in current- or voltage-clamp
experiments, respectively. The intracellular pipette solution con-
tained (in mM): 135 K gluconate, 10 KCl, 10 HEPES, 10 MgCl2, 2
Na ATP, 2 Na GTP; 280-285 mOsm, pH 7.3. Electrode position
within the slice was visualized by an infrared, differential
interference contrast microscope (Carl Zeiss, Axioskop 2 FS Plus)
captured with an infrared camera (Dage MT1, CCD100).
Electrodes were fabricated from borosilicate glass (Hilgenberg
#1405002, Malsfeld, Germany) to a diameter of approximately
2 mm to yield a mean pipette resistance of 6.560.3 MV (n = 27).
Positive pressure was retained while navigating through the OB
laminae until a high resistance seal (Re= 1.2 to 5.1 GV) was
obtained on a positionally-identified mitral cell neuron in the slice.
The whole-cell configuration was established by applying gentle
suction to the lumen of the pipette while monitoring resistance.
Each positionally-identified mitral cell was first sampled for
adequate resting potential (,-55 mV) and proper series resistance
(less than 40 MV) prior to initiating a series of current-clamp
recordings. Typically cells were injected in 50–100 pA steps for
1000 ms to generate a family of evoked action potential trains and
to determine the threshold to initiate a spike. Cells were then
stimulated with a long, perithreshold current step (ranging from 5 to
50 pA) of 5000 ms every 10 s to acquire spike frequency data; prior
and following 0.1 nemM (1 mg/mL) insulin (Roche, Florence, SC).
Since mitral cell firing is intrinsically intermittent and is character-
ized by variable spike clusters, classical means of computing spike
timing variability, such as peri-stimulus time histograms (PSTH),
were less suitable for the behavior of these neurons and therefore
alternative means of spike analyses were applied as described by
Balu and Strowbridge (2004) [15].
Data Acquisition and Statistical Analysis
Voltage-activated currents and current-evoked changes in
membrane voltage were measured either using an Axopatch-1B
integrating patch-clamp amplifier (Axon Instruments) or an EPC
10 (HEKA Elektronik). The analog signal was filtered at 2 kHz
and minimally digitally sampled every 100 ms. Generation of
voltage/current pulse protocols, data capture, and subsequent
storage was either through pClamp9 (Axon) or through Patch-
master (HEKA). Data were analyzed in pClamp10 or in Pulsefit
v8.6, in combination with the analysis packages Origin 6.0
(MicroCal Software), Quattro Pro 4X (Borland International), and
Igor Pro 6.0.2 (Wavemetrics) with the NeuroMatics 2.02 plugin.
Peak current magnitude and kinetics of inactivation and
deactivation of the Kv1.3 current recorded in voltage-clamp were
fit as previously described [8]. Spike analysis was performed using
the event detection software, Neuromatics. Unless otherwise
noted, the statistical design to compare electrophysiological
parameters was a paired, within-cell metric so that a paired t-
test could be applied at the 95% confidence level (a #0.05).
Biophysical values were always expressed as the mean 6 the
standard error of the mean (s.e.m.).
Insulin Intranasal Delivery
Insulin intranasal delivery (IND) was originally piloted for
Sprague Dawley rats by Thorne et al., 2004 [16], which we
modified for mice as fully described [14]. Briefly, for awake insulin
IND, mice were hand-restrained, placed in a supine position, and
given three, 10 ml drops of 5 mg/ml insulin or PBS vehicle, into
both nares simultaneously. A meniscus of solution was formed and
presented for inhalation by the awake mouse. Mice were given an
extra 10 ml if the subject forcibly ejected or sneezed out solution.
Figure 3. Insulin increases cluster length and decreases pause duration of perithreshold firing behavior in adult mitral cells. (A)
Representative firing patterns (top) and the associated raster plots (bottom) generated in response to acute insulin stimulation over time in an adult
mitral cell. Evoked activity was elicited using a 5 s long perithreshold current injection of 5 pA while recording near the natural resting potential of -
65 mV. Numbers indicate time in minutes (i.e. Insulin 10, 10 minutes post bath application) compared to basal activity (Control). Each line of the raster
plot represents action potential activity evoked during a 5000 ms pulse; complete raster is 20 consecutive pulses. (B) Example scatter plot of spike
frequency of a neuron treated with ACSF (ACSF) versus that of one treated with insulin (Insulin) at the arrow. (C) (top) Example histogram distribution
of the interspike interval (ISI) for a neuron prior (left) and following (right) insulin stimulation taken at Insulin 20. Plot was fitted by a Gaussian function
(solid line) to determine mean ISI as reported in inset. (bottom) Example peri-stimulus spike distribution for the neuron in panel A at Insulin 20 to
demonstrate change in first latency pattern of activity.
doi:10.1371/journal.pone.0024921.g003
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Mice were held supine for 5–10 sec after delivery to ensure all
fluid was inhaled. It was previously shown that intranasally-
delivered insulin-like growth factor reaches the OB with an
efficiency of 0.11% [14]. Based upon those calculations and the
equivalent molecular weight of insulin, it is estimated that 9 nM
insulin is the effective dose of insulin reaching the OB. IND was
repeated twice daily at 0700 and 1900 for eight days. On the
morning of the ninth day, mice were given a final treatment at
0700, and sacrificed three hours later for slice electrophysiology.
Results
Previous biophysical characterization of the cloned Kv1.3
channel has mapped the molecular targets of insulin modulation
by tyrosine phosphorylation via mutagenesis approaches in the –
and C-terminal aspects of the channel [2,3]. Given the low levels of
resting insulin in control or fat challenged Kv1.3-/- animals [13]
and our finding that both the IR kinase and the Kv1.3 channel are
resistant to phosphorylation following DIO in wild-type animals
[14], lead us to further investigate the channel’s function that could
link metabolic state to excitability of neurons in a brain region
expressing high levels of the channel [17]. We therefore sought to
explore the modulation of the native Kv1.3 channel by insulin in the
mitral cells of the olfactory bulb using an adult slice preparation. We
hypothesized that the olfactory bulb could function as a sensor of
metabolism by responding to levels of insulin, which would
modulate the excitability of its output neurons, whose outward
currents are largely contributed by Kv1.3 channels [3].
Insulin Increases Mitral Cell Firing Frequency and
Dampens Spike Adaptation
A total of 172 cells from 81 mice were recorded across all
combined electrophysiology experiments. Mitral cells were
identified in the olfactory bulb slice based upon their pyramidal
morphology when viewed under infrared differential contrast
optics and position within the mitral cell layer (Figure 1A). Since
there were no previous patch-clamp recordings reported for mitral
cells of adult rodents, we used comparison to membrane properties
described for postnatal animals [14,18] as a secondary guide for
positive identification, as well as YFP-thy1 mitral cell mice in a
limited number of recordings while optimizing the viability of our
slice preparation [19]. A sampling of the mean resting potential
(RMP) of the adult mitral cells (6161.8 mV; n= 12) and the mean
input resistance (220621.4 MV; n = 10) were in the same ranges
reported in postnatal rats and mice. The mean firing frequency in
response to graded step depolarizations of short duration ranging
from 25 to 200 pA showed positive correlation in terms of number
of spikes/s (Figure 1B) and a negative one in terms of the duration
of the interspike interval (ISI) (Figure 2A). Application of insulin
evoked a significant increase in firing frequency and a concomitant
decrease in ISI at all ranges of current step amplitudes (Figure 1B
and Figure 2A). Greater current step depolarizations (.200 pA)
caused spike adaptation and a reduction in mean firing frequency
in control recordings (Figure 1, see Time 0 in 1D). Most
interestingly, insulin largely abolished spike frequency adaptation
in response to the higher current injections (Figure 1D, Time 20,
103).
Insulin Shortens Pause Duration Between Spike Clusters
While Having Less Effect on Interspike Interval
Mitral cells have been reported to undergo the firing of
intermittent clusters of action potentials with a pause duration that
is independent of the magnitude of the evoking current step and that
persist in the presence of synaptic blockers [15]. To analyze this
behavior, we defined a spike cluster as three or more action
potentials preceded and followed by a pause of greater than 100 ms
(Figure 2B). In addition to the ability of insulin to modulate ISI
(calculated within a spike cluster or intracluster; Figure 2A), acute
bath application of insulin for as little as 15 minutes, caused a
significant shortening of the pause duration between spike clusters
(calculated as intercluster) (Figure 2B). To further investigate the
effect of insulin on this intrinsic firing activity observed in these
neurons, mitral cells were stimulated with perithreshold current steps
(5 to 50 pA) of long duration (5000 ms) while maintaining the cell
near its RMP (Figure 3). Under these conditions, action potential
clusters were clearly detectable and cells could continue firing for as
long as three hours without significant changes in access resistance
(mean value final Ra= 39.063.9 MV; n= 25). Significant changes in
the spike frequency, intraburst frequency, latency to first spike, and
the duration of the pause between spike clusters were first observed
at the ten minute time point following application of insulin and
became most prominent by visual inspection of the raster plot after
twenty minutes of stimulation (Table 1, Figure 3A). Most
Table 1. Changes in biophysical properties in mitral cells
following insulin application.
Voltage clamp Control Insulin
Peak transient current magnitude (pA) 3909.36440.7 (5) *2325.06266.0
Peak sustained current magnitude (pA) 3273.36319.6 (5) *2195.06305.2
Sustained/transient ratio (percent) 0.8660.07 (5) *0.7460.03
tInact (ms) 58.364.9 (4) 67.4613.0
tDeact (ms) 24.764.6 (5) 34.769.7
Current clamp – Evoked Firing Properties (25 pA)
Latency to first spike (ms) 1367.06316.0 (9) *158.0691.3
Spike frequency (Hz) 13.862.6 (7) *24.764.5
Intraburst frequency (Hz) 27.460.9 (9) *33.462.7
ISI (ms) 44.865.8 (7) 38.064.0
Spikes/cluster 18.963.8 (9) *42.466.4
Burst length (ms) 600.06139.2 (9) *1147.66173.1
Pause duration (ms) 1054.66138.4 (9) *598.66107.5
Current clamp – Evoked Action Potential Properties (200 pA)
Peak reversal (mV) 21.363.1 (7) *27.762.6
Width at half-maximum (ms) 1.560.07 (7) *1.260.08
10–90% rise time (ms) 2.560.08 (7) *1.760.09
1/e (ms) 1.260.08 (7) *1.060.08
* = Significantly-different mean values via paired t-test, a#0.05. Insulin
measurements represent the 20 minute time point following bath application
of 0.1 mM (1 mg/mL) insulin. tInact = the inactivation time constant, tDeact = the
deactivation time constant, spike frequency = calculated throughout step
depolarization, intraburst frequency = calculated during spike cluster, ISI =
interspike interval within a spike cluster, action potential cluster = defined as
three or more action potentials with less than 100 ms pause duration, pause
duration = duration between clusters, 1/e = action potential decay time.
Voltage-activated currents were measured using a Vh = -80 mV with a
depolarizing Vc = +40 mV of 400 ms in duration and an interpulse interval of
30-45 s. In voltage-clamp recordings in which tetrodotoxin was not applied, a
sustained/transient ratio was determined when spiking prevented subsequent
kinetic analysis. In current-clamp recordings, firing properties were determined
using a perithreshold current injection of 25 pA and 5000 ms duration. Action
potential properties were determined using a 200 pA current injection of
1000 ms duration using a 50 ms sampling frequency.
doi:10.1371/journal.pone.0024921.t001
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noteworthy, the number of spikes/cluster and cluster length
increased two-fold upon insulin stimulation, while the pause duration
was significantly reduced by 40% (Table 1). The time course for the
increase in the firing frequency of mitral cells in the adult slice
preparation (Figure 3B) was consistent with our previous determi-
nations of insulin-induced Kv1.3 current suppression in a primary
cell culture preparation (voltage-clamp configuration), as well as
insulin-dependent protein phosphorylation in native olfactory bulb
and heterologous expression systems [2,3]. A majority of the sampled
cells (.85%) failed to return to baseline firing following 30 minutes
to 2 h of washout with ACSF, also consistent with a persistent
biochemical modification following insulin stimulation. Finally,
analysis of the shape of the action potential, prior and following
acute insulin application, was performed using graded-step depolar-
izing current injections of short duration and higher sampling
frequency. Surprisingly, application of insulin for 20 minutes
significantly reduced the width of the action potential (calculated
at half-amplitude), increased the amplitude of the spike, and
decreased the spike decay time (Figure 4, Table 1).
Mitral Cell Firing Is Modulated by Insulin at the Level of
the Kv1.3 Channel
If the modulation of Kv1.3 was a predominant means of metabolic
sensing for the olfactory bulb, then we hypothesized that the neurons
should be insensitive to insulin in the absence of the channel. To test
whether the changes in mitral cell firing properties induced by insulin
were specifically mediated by Kv1.3 channels, we explored
neuromodulation in slices prepared from adult Kv1.3-/- mice. We
first characterized the basic biophysical properties of mitral cells in
slices from adult Kv1.3-/- mice, since this has never been reported.
Here we show that in comparison with wild-type mice, mitral cells
lacking Kv1.3 respond to lower current injections (lower threshold to
first spike), display a more depolarized RMP, an increased firing
frequency, a decreased latency to the first spike, and a decreased
pause duration between spike clusters (Figure 5). Basal biophysical
values are compared across genotypes in Table 2. Using an identical
perithreshold current injection paradigm as for wild-type neurons
(Figure 3), we found that the firing behavior of mitral cells in slices
from Kv1.3-/- mice was largely insensitive to the application of
insulin (Figure 6). In addition to loss of function experiments via gene
knock-out to define the selective involvement of Kv1.3 in sensing
insulin, we also used pharmacological means. Using a selective
blocker of Kv1.3 (ShK186), which binds the vestibule of the channel
at low pM affinity [20], we confirmed that block of the Kv1.3 protein
in mitral cells evoked an increase firing frequency as predicted
(Figure 7A). To determine the proportion of Kv1.3 conductance
modulated by insulin, we additionally performed voltage-clamp
experiments. We first demonstrated that ShK186 blocked a large
proportion of the outward voltage-activated currents in mitral cells,
demonstrating that Kv1.3 is a main contributor to the total potassium
current in these neurons (Figure 7B). In a separate set of experiments,
Figure 4. Insulin modulates action potential shape in adult mitral cells. (A) Example action potentials recorded in response to a 200 pA
current injection prior (Control) and following (Insulin) bath application of the hormone. (B) Line graphs of the action potential amplitude (Spike
amplitude), width (Width at K max), and falling phase (Spike decay time, 1/e) for a population of neurons recorded in ACSF (Control) and then
following 20 minutes of bath application of insulin (Insulin) in response to various current steps as noted. * = significantly-different current step by
paired t-test, a #0.05.
doi:10.1371/journal.pone.0024921.g004
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Figure 5. Spike firing properties in mitral cells compared across wild-type and Kv1.3-/- mice. (A) Representative action potential trains
evoked by various current steps as indicated in a mitral cell recorded from a wild-type (+/+) and Kv1.3-null (-/-) mouse, respectively. Cells were
recorded near the natural resting potential of -62 mV and evoked activity was elicited using a 2000 ms pulse duration. (B) Individual line plots of the
mean spikes per second within a spike cluster (Spikes/s), the interspike interval (ISI), latency to first action potential (Latency 1st spike), duration of the
spike cluster (Cluster length), and number of spikes per cluster (Spikes/cluster) are shown in relationship to current step. Data represent mean 6
s.e.m. values from a minimal of 20 recordings, acquired from 10–12 animals each, sampled from the two genotypes (+/+ = closed circles, -/- = open
circles). Data were fit by linear regression (lines), which were all significantly different by two-way analysis of covariance (ACNOVA) with respect to
magnitude but not slope. * = significantly different by one-way ANOVA, a #0.05, Student Newman Kuels (snk) followup test. Note that Latency 1st
spike failed to be fit by linear regression, so only the latter statistical metric could be applied. (C) Scatter plot of the relationship of resting membrane
potential (RMP) in mitral cells to genotype. Same symbols as in panel B; horizontal bar represents sampled mean, error bars represent s.e.m., and
* = significantly different by Student’s t-test, a#0.05. See also Table 2.
doi:10.1371/journal.pone.0024921.g005
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application of insulin caused significant reduction of the outward
voltage-activated current with no effect on the kinetics of activation or
inactivation (Table 1, Figure 7C). There is a residual, unidentified
current that is both insensitive to insulin and ShK186 (Figure 7D) at
concentrations previously demonstrated to phosphorylate and
suppress Kv1.3 currents or selectively block Kv1.3 over other Shaker
family members [3,20]. Also shown in this figure is the ShK186
sensitive, Kv1.3 current that remains following insulin modulation
(Figure 7D, subtraction).
Neuromodulation by Insulin Depends on Duration of
Exposure and Metabolic State
Long-term treatment with insulin may induce insulin resistance,
a physiological state that is representative of chronic management
of metabolic imbalance. We next tested the effect of chronic
application of insulin by two methods, first by intranasal delivery
of insulin over periods of days, and secondly by DIO that induces
a prediabetic blood chemistry of elevated insulin. We hypothesized
that chronic levels of insulin would modify biophysical properties
of the mitral cells by altering Kv1.3 basal phosphorylation [14].
Adult mice of at least two months of age underwent intranasal
delivery of insulin or PBS, twice daily for 8 days. This regimen
does not modify peripheral levels of insulin or glucose, but it
increases phosphorylation of IR kinase and Kv1.3 channel in the
olfactory bulb and it enhances olfactory discrimination, among
other behavioral phenotypes including anxiety and memory [14].
Following chronic insulin delivery, mitral cells displayed two
distinct firing patterns (Figure 8) that were not observed with
delivery of the PBS carrier alone. Sixty-four percent of recorded
neurons (n = 11) fired only a single, short spike cluster with a short
latency to first spike (Type I, Figure 8A), while 36% of recorded
neurons (n = 4) had sustained firing with a very high initial firing
frequency and short pauses between spike clusters (Type II,
Figure 8B). Regardless of which firing pattern was observed
following chronic intranasal insulin delivery, a subsequent acute
exposure to insulin (20 minute application) now caused a
pronounced lengthening of the pause duration, as opposed to
increasing the excitability of the neuron, and in Type I mitral cells
it additionally evoked a decrease in firing frequency (Table 3). The
firing frequency in Type I mitral cells significantly decreased by
28%, while that of Type II neurons fell by 17% but did not reach
statistical significance (see Table 3). In the latter class of adult
mitral cells, the pause duration between spike clusters was
significantly increased by 2 fold and the burst length was
concomitantly decreased (Table 3).
The second way of chronically inducing insulin levels, in order to
examine functional changes in mitral cell activity, was through
DIO. In adult obese mice that had been challenged with a MHF-
diet, three changes in action potential firing patterns were observed
in comparison to control fed, aged-matched mice. Thirty percent of
neurons (7 of 24) from fat challenged mice only fired a single action
potential in response to a minimal current step of 200 pA (data not
shown). Twenty-five percent (6 of 24) of recorded cells exhibited
changes in spike amplitude as shown in Figure 9A. In these mitral
cells, action potentials did not display full amplitude, there was
marked spike adaptation, and the threshold to the first evoked spike
was often two fold greater, even though the RMP did not signifi-
cantly differ between control and MHF-fed animals (Obese =
-63.660.8 mV (n= 40) vs. Control -64.066.3 mV (n= 27); Stu-
dent’s t-test, a# 0.05). The remaining 45% of sampled neurons (10
of 24) showed no changes in action potential amplitude, however,
the basal burst length was shorter and the ISIs within spike clusters
were shorter than those of control fed animals (see Table 2 vs.
Table 3 (100 pA step); Figure 9B,C). Unlike mice for which insulin
was chronically and centrally delivered intranasally, obese mice had
elevations in both glucose and serum insulin levels (data not shown)
and their firing patterns exhibited only slight responses to acute
stimulation with insulin (Figure 9A–C; Table 3). Mitral cells
displayed no response (Figure 9A) or an attenuated increase in spike
frequency (Figure 9C) upon acute insulin stimulation compared
with cells from control fed animals (Figure 3A), and had either no
reduction or a blunted reduction in pause duration and only a 30%
increase in burst length (Table 3). The results of the combined
chronic experiments, in which insulin was either elevated by IND or
DIO, demonstrate that the firing of these neurons in the olfactory
bulb is highly state dependent; long-term exposure to the hormone
insulin or a state of obesity can perturb modulation of intrinsic
excitability, which in turn can change the relay of sensory
information encoded by firing patterns.
Table 2. Biophysical properties in mitral cells compared
across genotype.
Voltage clamp Wildtype Kv1.3-/-
Peak transient current magnitude (pA) 35256265 (50) *31086232 (27)
Peak sustained current magnitude (pA) 27926223 (49) 24476291 (27)
Sustained/transient ratio (percent) 0.8060.01 (49) 0.7960.02 (27)
tInact (ms) 104616 (22)
tDeact (ms) 1768 (23)
Resting Membrane Potential
RMP (mV) -63.261.1 (40) *-57.961.0 (27)
Current clamp – Evoked Firing Properties (100 pA)
Latency to first spike (ms) 324.3696.1 (8) *171.0694.6 (8)
Spike frequency (Hz) 14.863.1 (9) 21.666.2 (8)
Intraburst frequency (Hz) 26.763.1 (9) 32.263.5 (8)
ISI (ms) 43.865.0 (8) *31.263.5(8)
Spikes/cluster 24.467.2 (8) *47.2611.7 (8)
Burst length (ms) 989.56286.3 (8) 1385.36286.7 (8)
Pause duration (ms) 8026233 (5) *5296123 (7)
Current clamp – Evoked Action Potential Properties (50 pA)
Amplitude (mV) 72.662.4 (7) *59.664.6 (7)
Hyperpolarization (mV) -15.961.3 (7) *-12.461.5 (7)
Width at half-maximum (ms) 1.460.1 (7) 1.560.1 (7)
10–90% rise time (ms) 0.5360.03 (7) 0.6160.04 (7)
1/e (ms) 1.260.06 (7) 1.260.08 (7)
* = Significantly-different mean values via a Student’s t-test, a #0.05. tInact =
the inactivation time constant, tDeact = the deactivation time constant, RMP =
resting membrane potential, spike frequency = calculated throughout step
depolarization, intraburst frequency = calculated during spike cluster, ISI =
interspike interval within a spike cluster, action potential cluster = defined as
three or more action potentials with less than 100 ms pause duration, burst
length = duration of the cluster, pause duration = duration between clusters,
1/e = action potential decay time. Voltage-activated currents were measured
using a Vh = -80 mV with a depolarizing Vc = +40 mV of 400 ms in duration
and an interpulse interval of 30–45 s. In voltage-clamp recordings in which
tetrodotoxin was not applied, a sustained/transient ratio was determined
when spiking prevented subsequent kinetic analysis. In current-clamp
recordings, firing properties were determined using a 100 pA current injection
of 4000 ms in duration. Action potential properties were determined using a
50 pA current injection of 1000 ms in duration with a 50 ms sampling
frequency.
doi:10.1371/journal.pone.0024921.t002
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Discussion
This study reveals a new function of the olfactory bulb as an
additional sensor of the body’s metabolic state and internal
chemistry, in addition to its well-recognized role to encode
external chemosensory stimuli. We discovered a link between
endocrine function, metabolism, and sensory neural activity that is
molecularly centered around the Kv1.3 channel, predominantly
expressed in mitral cells of the olfactory bulb. We found that the
action potential firing properties of mitral cells are differentially
modulated by acute and chronic levels of the hormone insulin.
Moreover, the changes in action potential firing patterns, as well as
the dampened response to insulin in mice made obese by a MHF-
diet challenge, have a significant impact on the function of sensory
systems in obese animals.
Our data predict that transient changes in insulin levels due to the
ingestion of food would modulate mitral cell action potential
frequency patterns to yield changes in electrical information relayed
to higher processing centers. Early studies by Pager et al. [21] who
monitored multi-unit electrical activity in the mitral cell layer in
satiated compared with hungry rats, were the first to suggest that
modulation of mitral cell activity may be driven by factors related to
metabolic state. We now show that a strong modulator in the
olfactory bulb is insulin. Acute exposure to insulin increases firing
frequency and shortens the pause duration between spike clusters in
mitral cells. It has been hypothesized [15] that the intrinsic
membrane properties that drive intermittent spike clusters in the
mitral cells are important for precisely timing spikes evoked by odor
presentation to encode olfactory information. The spikes per cluster
and length of the clusters are both enhanced by either gene-targeted
deletion or pharmacological block of the Kv1.3 channel [8,15]. The
fact that insulin decreases the pause duration to enhance
excitability, and the finding that Kv1.3-/- animals fail to
significantly increase spike frequency upon insulin stimulation, are
consistent with a central role of Kv1.3 channels in the modulatory
action of insulin. Indeed, the evoked firing properties of wild-type
neurons in response to insulin (Table 1) mirror those of untreated
Kv1.3-/- mice (Table 2). In particular, the spikes/cluster, pause
duration between spike clusters, and latency to first spike have
significant similarities. Since activity patterns in mitral cells are
thought to encode odor identity, it is interesting that insulin changes
these patterns of activity in wild-type mice to a similar extent as that
found in the Kv1.3-/- that have been previously characterized as
‘‘Super-smellers’’. In particular, suppression or targeted-deletion of
potassium conductances would be expected to principally shorten
the latency to the first spike as we observed. Junek et al. (2010) [22]
recently demonstrated that mitral cell spike latency was an excellent
predictor of odorant identity and hypothesized that latency might be
more important than frequency for coding. The slow onset of insulin
modulation as well as its ability to dramatically curtail spike
frequency adaptation, reveal, none-the-less, that the mitral cells
have the capacity to double their firing frequency in a sustained
manner upon acute hormone stimulation. Following chronic insulin
exposure, the mitral cell appears to have a different set point in
terms of firing properties, and a state dependency in respect to its
response to additional acute insulin stimulation.
Neurons from animals with diet-induced obesity also displayed
inherent physiological changes as reflected in their altered firing
patterns both under basal conditions and in response to acute
insulin stimulation. Diet-induced obesity, as well as genetic models
of obesity, affect the expression and biophysical properties of
channels and receptors in some tissues [23–25] and have no effect
in others [26]. Our results provide a possible mechanism of how
high-fat diet perturbs basal activity and insulin modulation of
mitral cells, namely through the modulation of Kv1.3 activity. It
would be very intriguing to reverse mice back to their original
body weight to determine how persistent the changes in firing
properties of mitral cells are.
The link between the olfactory system and energy balance
should not be unexpected, given that perception of odorants
drives food ingestion and selection [27]. It has been demonstrated
that the nutritional status modulates both behavioral and
immediate early gene expression in the olfactory bulb upon odor
stimulation [28]. While our study focused upon the modulatory
effect of insulin as one of the most important metabolic signals,
orexins, leptin, and cholecystokinin have also been reported as
regulatory molecules of olfactory behavior and odor-evoked and
spontaneous activity in the olfactory epithelium [28–31]. The
duration and target of the metabolic signal appears to
differentially affect the olfactory-based physiological response.
Savinger et al. [30] and Lacroix et al. [32] report a reduced
electro-olfactogram response upon acute insulin stimulation at
Figure 6. Insulin fails to significantly modulate mitral cell firing properties in Kv1.3-/- mice. Same as Figure 3 but for Kv1.3-/- mice as
opposed to wildtype.
doi:10.1371/journal.pone.0024921.g006
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Figure 7. Insulin inhibits voltage-activated currents in adult mitral cells that are carried predominantly by Kv1.3 channels. (A)
Representative current-clamp recording in a mitral cell prior (Control) and following a two minute bath application of the sea anemonie-derived
channel peptide (ShK186). Evoked activity was elicited using a 1 s long current injection of 25 pA while recording near the natural resting potential of
-65 mV. (B) Representative family of voltage-activated currents elicited in a mitral cell that was stepped in 10 mV depolarizing increments of 400 ms
duration to a Vc = +40 mV from a holding potential of -80 mV. Tetrodotoxin was added to control ACSF (Control, TTX) to eliminate unwanted
sodium channel activity that would contribute to unwanted spiking. The subtraction trace represents the Kv1.3 contribution to the total mitral cell
outward current. (C) (left) Same voltage paradigm as in panel B. The cell was first recorded in control ACSF (Control), followed by a 20 minute bath
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application of insulin (Insulin). (Right) Bar plot of the mean (6 s.e.m.) peak transient or sustained outward current prior (black bar) and following
insulin (stripped bar) stimulation. * = Significantly different by paired t-test, a#0.05. (D) Same cell as in panel C, where TTX was then added to isolate
outward currents and finally ShK186 was applied to uncover the Kv1.3 contribution that was modulated by insulin (Insulin, TTX, ShK186). The
unidentified residual current is mediated by channels that are both insulin and ShK186 resistant. The subtraction trace represents the remaining Kv1.3
and Na channel contributions that were not modulated by insulin.
doi:10.1371/journal.pone.0024921.g007
Figure 8. Insulin intranasal delivery (IND) changes basal firing behavior and leads to a reduced spike frequency following acute
insulin stimulation. Representative basal action potential activity and the associated raster plot generated in response to an 8 day insulin IND
(Control) and following subsequent, acute insulin stimulation over time (Insulin 20, Insulin 40). Two different patterns of basal action potential firing
behavior were observed following insulin IND, (A) Type I and (B) Type II, as reported in the text. Time notations and raster plot generation as in
Figure 3. Evoked activity was elicited using a 5 s long perithreshold current injection of 50 pA while recording near the natural resting potential of
-63 mV. See also Table 3.
doi:10.1371/journal.pone.0024921.g008
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the epithelium. By contrast, chronic intranasal delivery of insulin
increases olfactory discrimination but not odor threshold as
determined by behavioral assessments [14], while increasing basal
mitral cell firing rates (Figure 8). Subsequent opposite, or
dampened modulation, by acute insulin stimulation following
chronic changes in brain insulin (intranasal) or peripheral blood
chemistry (DIO), demonstrate that there is a state dependency in
the ability of the olfactory sensory system to detect metabolic
changes. Lecoq et al. [33] have determined the relationship
between capillary density and cellular metabolism, with fine
spatial resolution in the olfactory bulb. Their measurements of
tissue oxygen consumption during odor stimulation suggest that
there is a great use of oxygen due to neuronal dendritic activation
within the glomerulus. Parallel evidence in the modality of taste
demonstrates that the metabolic status of the animal, in terms of
level of GLP-1, glucagon, leptin, or endocannabinoids, for
example, regulates sweet taste sensitivity [31,34–36]. Yee et al.
(2011) [37] recently reported the expression of glucose transport-
ers, a sodium-glucose co-transporter, and two components of the
ATP-gated K metabolic sensor in type 1 taste receptor 3-(T1r3)
expressing neurons. Intriguingly, the chemoreception of fat has
been proposed to involve the inhibition of a potassium delayed-
rectifier channel, whereby an obesity prone strain of rats was
found to be more sensitive in the detection of fatty acids and
express higher channel densities [38–40].
Our data provide exciting lines of evidence for Kv1.3 channel as
a potential sensor of metabolism within the OB. We have
previously demonstrated that Kv1.3 is a target of insulin
phosphorylation that exhibits resistance to phosphorylation
following obesity [14]. Loss of Kv1.3 causes an increase in
metabolism and a resistance to diet- and genetic-induced obesity
[8,10,12] (Tucker et al., submitted). Moreover, in support of a
central target for metabolism, we have recently demonstrated that
Kv1.3-/- mice are no longer resistant to DIO and display
decreased metabolism following bilateral olfactory bulbectomy
[13]. A recent polymorphism in the human Kv1.3 gene that
functionally elicits a gain in function has been associated with
impaired glucose tolerance, lower insulin sensitivity, and impaired
olfactory ability in male homozygous carriers [41,42]. Kv1.3
channel, as a reported ‘‘diabetes risk allele’’ in humans, may
represent an important candidate gene for therapeutic interven-
tion [43]. Straub et al. (2011) [44] failed to alter glucose uptake by
pharmacological inhibition of peripheral Kv1.3 channels, even
though Kv1.3-/- mice have lower fasting glucose levels and lower
blood glucose during a MHF-diet challenge [11,12] (Tucker et al.,
submitted). Therefore, the Kv1.3 target for therapeutic interven-
Table 3. Changes in evoked firing properties in mitral cells following IND insulin application and diet-induced obesity.
IND insulin application – 100 pA Basal Insulin
Type 1
Intraburst frequency (Hz) 41.3612.4 (7) *21.765.6
ISI (ms) 34.563 (7) 29.864
Spikes/cluster 2.661.1 (7) *1.160.1
Burst length (ms) 79.8621.4 (7) none
Pause duration (ms) none none
Type II
Intraburst frequency (Hz) 35.764.7 (4) 29.665
ISI (ms) 31.163.9 (4) 28.861.9
Spikes/cluster 37.166.4 (4) 29.860.4
Burst length (ms) 1319.56382 (4) *806.4638.1
Pause duration (ms) 707.2698.8 (4) *1472.66206.9
Diet-induced obesity – 100 pA
Spike Amplitude Changes
Intraburst frequency (Hz) 42.765.8 (6) 41.162.3
ISI (ms) 20.662.3 (6) 17.661.5
Spikes/cluster 25.5612.3 (6) 12.063.6
Burst length (ms) 505.06191 (6) 682.06360.2
Pause duration (ms) 964.46644 (6) 877.06398.9
Regular Amplitude
Intraburst frequency (Hz) 42.962.8 (10) 42.862.2
ISI (ms) 23.961.8 (10) 22.562.0
Spikes/cluster 22.163.7 (10) *31.064.4
Burst length (ms) 568.8693.5 (10) *758.2672.0
Pause duration (ms) 1848.76201.3 (10) *1408.16152.7
* = Significantly-different mean values via paired t-test, a #0.05. Insulin measurements represent the 20 minute time point following bath application of 0.1 mM (1 mg/
mL) insulin. Intraburst frequency = calculated during spike cluster, ISI = interspike interval within a spike cluster, action potential cluster = defined as three or more
action potentials with less than 100 ms pause duration, pause duration = duration between clusters. For these current-clamp recordings, firing properties were
determined using a perithreshold current injection of 100 pA and 5000 ms duration.
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tion may be centrally located and our combined data support the
OB as a potential locus. The fact that the action potential signaling
output of the OB, as regulated by Kv1.3 channels, is modulated by
the metabolic state of the animal, may provide an array of
intriguing questions for future examination of the OB as an
additional target for energy homeostasis and balance tied with
odor perception and food selection.
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